VERGENT BIOSCIENCE, INC.

Profile

Company Names

VERGENT BIOSCIENCE, INC.

Addresses

5810 W 78TH ST, STE 222, MINNEAPOLIS, MN 55439

5810 W. 78TH STREET, SUITE 222, MINNEAPOLIS, MN 55439

420 N 5TH ST, #500, MINNEAPOLIS, MN 55401

Phone Numbers

612-928-6515
9524263772

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$57,046,126.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-07 
$18,673,277.00 
$31,957,273.00 
$13,283,996.00 
Equity 
4
2025-02-03 
$3,750,000.00 
$5,000,000.00 
$1,250,000.00 
Debt 
3
2022-08-17 
$21,542,628.00 
$22,090,063.00 
$547,435.00 
Equity 
2
2021-11-08 
$1,163,814.00 
$2,000,000.00 
$836,186.00 
Debt 
1
2018-05-18 
$11,916,407.00 
$11,916,407.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAMUEL 
 
BANKS 
DIRECTOR
SAMUEL 
DEAN 
BANKS 
DIRECTOR
SAMUEL 
 
DEAN BANKS 
DIRECTOR
BOBBY 
 
HELMEDAG 
DIRECTOR
JEFF 
 
JULKOWSKI 
DIRECTOR
JEFFREY 
 
JULKOWSKI 
DIRECTOR, PROMOTER
JOHN 
 
SANTINI 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
T. 
SANTINI, JR. 
EXECUTIVE OFFICER, DIRECTOR
MARGO 
 
SHOUP 
DIRECTOR
ANITA 
 
WATKINS 
DIRECTOR
ANITA 
 
WILSON 
DIRECTOR
JEFFREY 
 
YURECKO 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-02-03 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-02-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-11-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-18 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#